TP53 and Myocardial fibrosis: Nonetheless, there is no report on whether storax can effectively ameliorate myocardial fibrosis and cardiac diastolic dysfunction by modulating the AT1R/Ankrd1/P53 pathway to induce cardiomyocyte apoptosis.